Esters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
申请人:Sigma-Tau Industrie
Farmaceutiche Riunite S.p.A.
公开号:EP0442850A1
公开(公告)日:1991-08-21
The esters of acyl L-carnitines with gamma-hydroxybutyric acid in the form of pharmacologically acceptable salts of formula (I)
wherein X⁻ is the anion of a pharmacologically acceptable salt, e.g. chloride, bromide, orotate, acid aspartate, acid citrate, acid phosphate, acid fumarate, lactate, acid maleate, acid oxalate, acid sulfate and glucosephosphate or in the form of inner salts of formula (I′)
wherein R is a straight or branched acyl group having from 2 to 5 carbon atoms, such as e.g. acetyl, propionyl, n-butyryl, isobutyryl and isovaleryl, are active in inhibiting neuronal degeneration (as it occurs in Alzheimer's senile dementia and Parkinson's disease) and in the treatment of coma.
酰基 L-肉碱与γ-羟基丁酸的酯,其形式为药理学上可接受的式 (I) 盐
其中 X-是药理学上可接受的盐的阴离子,如氯化物、溴化物、乳清酸盐、酸天冬氨酸盐、酸柠檬酸盐、酸磷酸盐、酸富马酸盐、乳酸盐、酸马来酸盐、酸草酸盐、酸硫酸盐和葡萄糖磷酸盐,或以式(I′)内盐的形式存在
其中 R 是具有 2 至 5 个碳原子的直链或支链酰基,如乙酰基、丙酰基、正丁酰基、异丁酰基和异戊酰基等,它们在抑制神经元变性(如阿尔兹海默氏老年痴呆症和帕金森氏病中发生的变性)和治疗昏迷方面具有活性。